Do calcium antagonists have a place in the treatment of mood disorders?
Höschl
C
C
Department of Psychiatry, 3rd School of Medicine, Charles University, Prague, Czechoslovakia.
D000341:Affective Disorders, Psychotic / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000188:drug therapy; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000134:cerebrospinal fluid / Q000494:pharmacology / Q000627:therapeutic use*; D004095:Dihydropyridines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D019964:Mood Disorders / Q000188:drug therapy*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D011293:Premenstrual Syndrome / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D014700:Verapamil / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D011619:Psychotropic Drugs; D014700:Verapamil; D002118:Calcium